Navigation Links
TransUnion Addresses Ohio Attorney General's Concerns Surrounding Non-Profit Tax-Exempt Status
Date:2/25/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:AUL Action Challenges Planned Parenthood to Reveal Financial Interest in Health Care Legislation 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 2Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 3Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 4Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:Emergency Medical Associates (EMA) Launches Comprehensive Wellness Program with EngagementHealth(R) 2
Other Medicine News:Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 2Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 3Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 4Health News: Brain Aneurysm Rupture Risk Tied to Location, Size 2Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 2Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 3Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 4Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Video: One A Day(R) and Ellen DeGeneres Team Up to Deliver a Message to Women About Breast Cancer Through The 'One A Day Women's Wake-Up Call' Program 2Health News:Video: One A Day(R) and Ellen DeGeneres Team Up to Deliver a Message to Women About Breast Cancer Through The 'One A Day Women's Wake-Up Call' Program 3
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Aethlon Medical Releases Shareholder Letter 57187 1Aethlon Medical Releases Shareholder Letter 57187 2Aethlon Medical Releases Shareholder Letter 57187 3Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 1Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 2Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 1Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 5